Panacea Life Sciences Holdings, Inc. Business Combination, Consideration Transferred
Panacea Life Sciences Holdings, Inc. (PLSH) reported Business Combination, Consideration Transferred of $2.94 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2019-08-14
- Panacea Life Sciences Holdings, Inc. business combination, consideration transferred for the quarter ending 2019-06-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. business combination, consideration transferred for the quarter ending 2019-03-31 was $2.94M.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month |
|---|---|---|
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $2.94M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.94M 10-Q · filed 2019-05-20 |